Article and Video CATEGORIES

Cancer Journey

Search By

Carlea has over 20 years of experience in nonprofit management and health advocacy. In October 2013, she joined The Global Resource for Advancing Cancer Education as its first executive director. She directs its growth in revenue, outreach and programs.

30 Days of Thanks and Lung Cancer

November is a month of gratitude in the U.S. It is also Lung Cancer Awareness Month (LCAM). Cancer patients have a unique perspective on gratitude, so it is only fitting that we combine them for our second LCAM Gratitude Campaign.

Each day this month, through a series of videos and photos, you'll meet lung cancer patients and their families who find joy in the little things (like cupcakes) and big things (like cancer research). Most of the campaign will happen on social media – on our Twitter, Facebook, YouTube, and Instagram feeds – so be sure to follow us on at least one of those platforms, where we hope you'll also share your own photos or thoughts on gratitude.

Along the way, we'll provide information about lung cancer treatments - both currently available options and discussions about what may or may not be on the horizon - that patients can take to their doctors. We encourage you to share it with the lung cancer patients and caregivers in your life so that they can benefit from it as well.

To kick off the gratitude, we would like to thank Keith Singer at Catch It in Time, who produced the videos, to Gilles Frydman and Laya Dogmetchi who took the portraits you will see throughout the month, to the patients and caregivers who stepped in front of our cameras with open and grateful hearts, and to you, the people who visit the GRACE website and read our materials on a regular basis. Thank you for appreciating our work.

 

And thanks to the following companies for their support of our LCAM 2016 program

Celgene 2015B-I for weblargeLilly redgenentech-logo-750

 

 

Next Previous link

Previous PostNext Post

Related Content

Image
Trial data ASCO 2024
Video
In this video series from ASCO 2024, Drs. Aakash Desai and Fauwzi Abu Rous discuss trial dates and clinical data as presented at the 2024 ASCO. To watch the complete playlist, click here.         
Image
Bladder Cancer Video Library 2024
Video
Dr. Petros Grivas discusses intravesical treatment for patients with nonmuscle invasive, or early-stage, bladder cancer, the importance of participating in clinical trials for bladder cancer, combination therapy options for patients with metastatic or incurable bladder cancer, and the importance of family history of cancer and discussing that history with your doctor.
Image
Case Based Panel
Video
The panel discusses treatment options for a patient diagnosed with EGFR Exon 19 Deletion NSCLC and examines data from the Laura Trial, a patient with a smoking history and diagnosis of small cell lung cancer, and how the Adriatic Study factors into decisions, and a patient with NSCLC adenocarcinoma, and a EGFR Exon 21 L858R Alteration, and how data from the Flaura 2 Trial can impact treatment decisions.

Forum Discussions

Hi elysianfields and welcome to Grace.  I'm sorry to hear about your father's progression. 

 

Unfortunately, lepto remains a difficult area to treat.  Recently FDA approved the combo Lazertinib and Amivantamab...

Hello Janine, thank you for your reply.

Do you happen to know whether it's common practice or if it's worth taking lazertinib without amivantamab? From all the articles I've come across...

Hi elysianfields,

 

That's not a question we can answer. It depends on the individual's health. I've linked the study comparing intravenous vs. IV infusions of the doublet lazertinib and amivantamab...

Recent Comments

JOIN THE CONVERSATION
I could not find any info on…
By JanineT GRACE … on
Hi elysianfields,

 

That's…
By JanineT GRACE … on
Hello Janine, thank you for…
By elysianfields on
EGFR
By happybluesun on